Middle East and Africa Veterinary Vaccines Market Size Expands at CAGR of 5.42% to Cross USD 648 Million by 2030
Middle East and Africa Veterinary Vaccines Market is propelled by growing awareness about animal health, increasing pet ownership, rising incidence of zoonotic diseases, government initiatives for animal vaccination, and advancements in veterinary healthcare.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Middle East and Africa Veterinary Vaccines Market size at USD 472.06 million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Middle East and Africa Veterinary Vaccines Market size to grow at a CAGR of 5.42% reaching a value of USD 648.06 million by 2030. The Middle East and Africa Veterinary Vaccines Market is propelled by rising awareness about animal health, growing livestock population, and the prevalence of infectious diseases. A growing demand for protein-rich food products and the need to enhance agricultural productivity contribute to the market expansion. Government initiatives to control and prevent animal diseases, coupled with advancements in biotechnology, further drive vaccine adoption. Additionally, a surge in companion animal ownership and the emergence of zoonotic diseases underscore the importance of veterinary vaccines, fostering market growth in Middle East and Africa.
Opportunity – Increasing demand for organic and sustainable livestock production
The Middle East and Africa Veterinary Vaccines Market is propelled by the burgeoning demand for organic and sustainable livestock production. As consumers prioritize healthier and ethically sourced animal products, the market experiences a surge in demand for veterinary vaccines that support sustainable farming practices. The shift toward organic livestock production ensures the well-being of animals and also emphasizes the importance of disease prevention, driving the adoption of advanced veterinary vaccines in the region.
Impact of Escalating Geopolitical Tensions on Middle East and Africa Veterinary Vaccines Market
The escalating geopolitical tensions in the Middle East and Africa have added a layer of uncertainty and volatility to the Veterinary Vaccines Market in the region, further compounded by the Israel-Hamas conflict and Russia-Ukraine war. Economic sanctions and geopolitical challenges have created ripple effects across industries, influencing consumer sentiment and purchasing behaviors. In the context of recent tensions between Israel and its neighbors, various industries face potential revenue impacts. However, the Israeli government's strong focus on national security, including biosecurity, highlights the crucial role of the veterinary vaccines sector. Despite broader economic challenges, the market remains essential for preserving animal populations, ensuring food security, and preventing bioterrorism. In navigating these complex dynamics, businesses must adopt agile and responsive veterinary vaccine strategies to address evolving consumer preferences and geopolitical landscape.
Middle East and Africa Veterinary Vaccines Market
Segmental Coverage
Middle East and Africa Veterinary Vaccines Market – By Type
Based on type, Middle East and Africa Veterinary Vaccines Market is divided into Poultry Vaccine, Livestock Vaccines (Bovine Vaccines and Small Ruminant Vaccines) Companion Animal Vaccines (Feline Vaccines and Canine Vaccines), and Aquaculture Vaccine segments. The livestock vaccines segment, encompassing bovine vaccines and small ruminant vaccines segment is the largest in the Middle East and Africa Veterinary Vaccines Market. The segment plays a pivotal role in safeguarding the health of cattle and small ruminants, contributing significantly to the overall veterinary vaccine market in the region. With a focus on livestock health and welfare, these vaccines address the unique needs of bovine and small ruminant populations, reflecting the importance of the agricultural and farming sectors in the Middle East and Africa.
Middle East and Africa Veterinary Vaccines Market – By Technology
By technology, the Middle East and Africa Veterinary Vaccines Market is divided into Live Attenuated Vaccines, Inactivated Vaccines (Toxoid Vaccines and Recombinant Vaccines), and Conjugate Vaccines segments. The inactivated vaccines segment, further categorized into toxoid vaccines and recombinant vaccines segments dominates the market share. The segment involves vaccines that are either deactivated or genetically engineered, offering a wide range of applications in veterinary medicine. Inactivated vaccines are crucial in preventing diseases among animals, and the toxoid and recombinant subcategories highlight the advanced technologies employed for heightened efficacy. The segment's prominence underscores the region's emphasis on innovative veterinary healthcare solutions, contributing significantly to the overall market landscape.
Competitive Landscape
Middle East and Africa Veterinary Vaccines Market is fiercely competitive. Major companies in the market include BIOVAC, Boehringer Ingelheim International GmbH, Ceva, Elanco, Hester Biosciences Limited, Merck & Co., Inc., NEOGEN Corporation, Virbac, and Zoetis Inc. These companies use various strategies, including increasing investments in their R&D activities, mergers, and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in the Middle East and Africa Veterinary Vaccines Market.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Middle East and Africa Veterinary Vaccines Market. It also highlights the factors driving forecasts of total Market size. The report promises to provide recent technology trends in Middle East and Africa Veterinary Vaccines Market and industry insights to help decision-makers make sound strategic decisions. Further, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
- 1. Research Framework
- 1.1. Research Objective
- 1.2. Technology Overview
- 1.3. Market Segmentation
- 2. Executive Summary
- 3. Middle East and Africa Veterinary Vaccines Market Insights
- 3.1. Industry Value Chain Analysis
- 3.2. DROC Analysis
- 3.2.1. Growth Drivers
- 3.2.2. Growth Drivers
- 3.2.2.1. Rising prevalence of animal diseases
- 3.2.2.2. Growing awareness of animal welfare
- 3.2.3. Restraints
- 3.2.3.1. High cost of vaccines
- 3.2.3.2. Lack of awareness of vaccination benefits
- 3.2.4. Opportunities
- 3.2.4.1. Increasing demand for organic and sustainable livestock production
- 3.2.4.2. Development of new vaccines
- 3.2.5. Challenges
- 3.2.5.1. Availability of counterfeit vaccines
- 3.2.5.2. Lack of cold chain infrastructure
- 3.3. Technological Advancements/Recent Developments
- 3.4. Regulatory Framework
- 3.5. Porter’s Five Forces Analysis
- 3.5.1. Bargaining Power of Suppliers
- 3.5.2. Bargaining Power of Buyers
- 3.5.3. Threat of New Entrants
- 3.5.4. Threat of Substitutes
- 3.5.5. Intensity of Rivalry
- 4. Middle East and Africa Veterinary Vaccines Market Overview
- 4.1. Market Size & Forecast, 2019–2030
- 4.1.1. By Value (USD Million)
- 4.2. Market Share and Forecast
- 4.2.1. By Type
- 4.2.1.1. Poultry Vaccine
- 4.2.1.2. Livestock Vaccines
- 4.2.1.2.1. Bovine Vaccines
- 4.2.1.2.2. Small Ruminant Vaccines
- 4.2.1.3. Companion Animal Vaccines
- 4.2.1.3.1. Feline Vaccines
- 4.2.1.3.2. Canine Vaccines
- 4.2.1.3.3. Others
- 4.2.1.4. Aquaculture Vaccine
- 4.2.1.5. Others
- 4.2.2. By Technology
- 4.2.2.1. Live Attenuated Vaccines
- 4.2.2.2. Inactivated Vaccines
- 4.2.2.3. Toxoid Vaccines
- 4.2.2.4. Recombinant Vaccines
- 4.2.2.5. Conjugate Vaccines
- 4.2.2.6. Others
- 4.2.3. By Disease
- 4.2.3.1. Porcine Disease
- 4.2.3.2. Poultry Disease
- 4.2.3.3. Livestock Disease
- 4.2.3.4. Companion Animal Disease
- 4.2.3.5. Others
- 4.2.4. By Distribution Channel
- 4.2.4.1. Oral Vaccines
- 4.2.4.2. Injection Vaccines
- 4.2.4.3. Intranasal Spray Vaccines
- 4.2.5. By Country
- 4.2.5.1. Saudi Arabia
- 4.2.5.2. UAE
- 4.2.5.3. Qatar
- 4.2.5.4. Kuwait
- 4.2.5.5. South Africa
- 4.2.5.6. Nigeria
- 4.2.5.7. Algeria
- 4.2.5.8. Rest of MEA
- 5. Saudi Arabia Veterinary Vaccines Market
- 5.1. Market Size & Forecast, 2019–2030
- 5.1.1. By Value (USD Million)
- 5.2. Market Share & Forecast
- 5.2.1. By Type
- 5.2.2. By Technology
- 5.2.3. By Disease
- 5.2.4. By Distribution Channel
- 6. UAE Veterinary Vaccines Market
- 6.1. Market Size & Forecast, 2019–2030
- 6.1.1. By Value (USD Million)
- 6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By Technology
- 6.2.3. By Disease
- 6.2.4. By Distribution Channel
- 7. Qatar Veterinary Vaccines Market
- 7.1. Market Size & Forecast, 2019–2030
- 7.1.1. By Value (USD Million)
- 7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Technology
- 7.2.3. By Disease
- 7.2.4. By Distribution Channel
- 8. Kuwait Veterinary Vaccines Market
- 8.1. Market Size & Forecast, 2019–2030
- 8.1.1. By Value (USD Million)
- 8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Technology
- 8.2.3. By Disease
- 8.2.4. By Distribution Channel
- 9. South Africa Veterinary Vaccines Market
- 9.1. Market Size & Forecast, 2019–2030
- 9.1.1. By Value (USD Million)
- 9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Technology
- 9.2.3. By Disease
- 9.2.4. By Distribution Channel
- 10. Nigeria Veterinary Vaccines Market
- 10.1. Market Size & Forecast, 2019–2030
- 10.1.1. By Value (USD Million)
- 10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Technology
- 10.2.3. By Disease
- 10.2.4. By Distribution Channel
- 11. Algeria Veterinary Vaccines Market
- 11.1. Market Size & Forecast, 2019–2030
- 11.1.1. By Value (USD Million)
- 11.2. Market Share & Forecast
- 11.2.1. By Type
- 11.2.2. By Technology
- 11.2.3. By Disease
- 11.2.4. By Distribution Channel
- 12. Rest of MEA Veterinary Vaccines Market
- 12.1. Market Size & Forecast, 2019–2030
- 12.1.1. By Value (USD Million)
- 12.2. Market Share & Forecast
- 12.2.1. By Type
- 12.2.2. By Technology
- 12.2.3. By Disease
- 12.2.4. By Distribution Channel
- 13. Competitive Landscape
- 13.1. List of Key Players and Their Offerings
- 13.2. Middle East and Africa Veterinary Vaccines Market Share Analysis, 2023
- 13.3. Competitive Benchmarking, By Operating Parameters
- 13.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
- 14. Impact of Escalating Geopolitical Tensions on Middle East and Africa Veterinary Vaccines Market
- 15. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
- 15.1. BIOVAC
- 15.2. Boehringer Ingelheim International GmbH
- 15.3. Ceva
- 15.4. Elanco
- 15.5. Hester Biosciences Limited
- 15.6. Merck & Co., Inc.
- 15.7. NEOGEN Corporation
- 15.8. Virbac
- 15.9. Zoetis Inc.
- 15.10. Other Prominent Players
- 16. Key Strategic Recommendations
- 17. Research Methodology
- 17.1. Qualitative Research
- 17.1.1. Primary & Secondary Research
- 17.2. Quantitative Research
- 17.3. Market Breakdown & Data Triangulation
- 17.3.1. Secondary Research
- 17.3.2. Primary Research
- 17.4. Breakdown of Primary Research Respondents, By Region
- 17.5. Assumptions & Limitations
- *Financial information of non-listed companies can be provided as per availability.
- **The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable
- List of Figures
- Figure 1 Middle East and Africa Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
- Figure 2 Middle East and Africa Veterinary Vaccines Market Share, By Type, By Value, 2019–2030
- Figure 3 Middle East and Africa Veterinary Vaccines Market Share, By Technology, By Value, 2019–2030
- Figure 4 Middle East and Africa Veterinary Vaccines Market Share, By Disease, By Value, 2019–2030
- Figure 5 Middle East and Africa Veterinary Vaccines Market Share, By Distribution Channel, By Value, 2019–2030
- Figure 6 Middle East and Africa Veterinary Vaccines Market Share, By Country, By Value, 2019–2030
- Figure 7 Saudi Arabia Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
- Figure 8 Saudi Arabia Veterinary Vaccines Market Share, By Type, By Value, 2019–2030
- Figure 9 Saudi Arabia Veterinary Vaccines Market Share, By Technology, By Value, 2019–2030
- Figure 10 Saudi Arabia Veterinary Vaccines Market Share, By Disease, By Value, 2019–2030
- Figure 11 Saudi Arabia Veterinary Vaccines Market Share, By Distribution Channel, By Value, 2019–2030
- Figure 12 UAE Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
- Figure 13 UAE Veterinary Vaccines Market Share, By Type, By Value, 2019–2030
- Figure 14 UAE Veterinary Vaccines Market Share, By Technology, By Value, 2019–2030
- Figure 15 UAE Veterinary Vaccines Market Share, By Disease, By Value, 2019–2030
- Figure 16 UAE Veterinary Vaccines Market Share, By Distribution Channel, By Value, 2019–2030
- Figure 17 Qatar Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
- Figure 18 Qatar Veterinary Vaccines Market Share, By Type, By Value, 2019–2030
- Figure 19 Qatar Veterinary Vaccines Market Share, By Technology, By Value, 2019–2030
- Figure 20 Qatar Veterinary Vaccines Market Share, By Disease, By Value, 2019–2030
- Figure 21 Qatar Veterinary Vaccines Market Share, By Distribution Channel, By Value, 2019–2030
- Figure 22 Kuwait Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
- Figure 23 Kuwait Veterinary Vaccines Market Share, By Type, By Value, 2019–2030
- Figure 24 Kuwait Veterinary Vaccines Market Share, By Technology, By Value, 2019–2030
- Figure 25 Kuwait Veterinary Vaccines Market Share, By Disease, By Value, 2019–2030
- Figure 26 Kuwait Veterinary Vaccines Market Share, By Distribution Channel, By Value, 2019–2030
- Figure 27 South Africa Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
- Figure 28 South Africa Veterinary Vaccines Market Share, By Type, By Value, 2019–2030
- Figure 29 South Africa Veterinary Vaccines Market Share, By Technology, By Value, 2019–2030
- Figure 30 South Africa Veterinary Vaccines Market Share, By Disease, By Value, 2019–2030
- Figure 31 South Africa Veterinary Vaccines Market Share, By Distribution Channel, By Value, 2019–2030
- Figure 32 Nigeria Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
- Figure 33 Nigeria Veterinary Vaccines Market Share, By Type, By Value, 2019–2030
- Figure 34 Nigeria Veterinary Vaccines Market Share, By Technology, By Value, 2019–2030
- Figure 35 Nigeria Veterinary Vaccines Market Share, By Disease, By Value, 2019–2030
- Figure 36 Nigeria Veterinary Vaccines Market Share, By Distribution Channel, By Value, 2019–2030
- Figure 37 Algeria Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
- Figure 38 Algeria Veterinary Vaccines Market Share, By Type, By Value, 2019–2030
- Figure 39 Algeria Veterinary Vaccines Market Share, By Technology, By Value, 2019–2030
- Figure 40 Algeria Veterinary Vaccines Market Share, By Disease, By Value, 2019–2030
- Figure 41 Algeria Veterinary Vaccines Market Share, By Distribution Channel, By Value, 2019–2030
- Figure 42 Rest of MEA Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
- Figure 43 Rest of MEA Veterinary Vaccines Market Share, By Type, By Value, 2019–2030
- Figure 44 Rest of MEA Veterinary Vaccines Market Share, By Technology, By Value, 2019–2030
- Figure 45 Rest of MEA Veterinary Vaccines Market Share, By Disease, By Value, 2019–2030
- Figure 46 Rest of MEA Veterinary Vaccines Market Share, By Distribution Channel, By Value, 2019–2030
- List of Tables
- Table 1 Middle East and Africa Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
- Table 2 Middle East and Africa Veterinary Vaccines Market Size, By Type, By Value, 2019–2030
- Table 3 Middle East and Africa Veterinary Vaccines Market Size, By Technology, By Value, 2019–2030
- Table 4 Middle East and Africa Veterinary Vaccines Market Size, By Disease, By Value, 2019–2030
- Table 5 Middle East and Africa Veterinary Vaccines Market Size, By Distribution Channel, By Value, 2019–2030
- Table 6 Middle East and Africa Veterinary Vaccines Market Size, By Country, By Value, 2019–2030
- Table 7 Saudi Arabia Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
- Table 8 Saudi Arabia Veterinary Vaccines Market Size, By Type, By Value, 2019–2030
- Table 9 Saudi Arabia Veterinary Vaccines Market Size, By Technology, By Value, 2019–2030
- Table 10 Saudi Arabia Veterinary Vaccines Market Size, By Disease, By Value, 2019–2030
- Table 11 Saudi Arabia Veterinary Vaccines Market Size, By Distribution Channel, By Value, 2019–2030
- Table 12 UAE Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
- Table 13 UAE Veterinary Vaccines Market Size, By Type, By Value, 2019–2030
- Table 14 UAE Veterinary Vaccines Market Size, By Technology, By Value, 2019–2030
- Table 15 UAE Veterinary Vaccines Market Size, By Disease, By Value, 2019–2030
- Table 16 UAE Veterinary Vaccines Market Size, By Distribution Channel, By Value, 2019–2030
- Table 17 Qatar Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
- Table 18 Qatar Veterinary Vaccines Market Size, By Type, By Value, 2019–2030
- Table 19 Qatar Veterinary Vaccines Market Size, By Technology, By Value, 2019–2030
- Table 20 Qatar Veterinary Vaccines Market Size, By Disease, By Value, 2019–2030
- Table 21 Qatar Veterinary Vaccines Market Size, By Distribution Channel, By Value, 2019–2030
- Table 22 Kuwait Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
- Table 23 Kuwait Veterinary Vaccines Market Size, By Type, By Value, 2019–2030
- Table 24 Kuwait Veterinary Vaccines Market Size, By Technology, By Value, 2019–2030
- Table 25 Kuwait Veterinary Vaccines Market Size, By Disease, By Value, 2019–2030
- Table 26 Kuwait Veterinary Vaccines Market Size, By Distribution Channel, By Value, 2019–2030
- Table 27 South Africa Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
- Table 28 South Africa Veterinary Vaccines Market Size, By Type, By Value, 2019–2030
- Table 29 South Africa Veterinary Vaccines Market Size, By Technology, By Value, 2019–2030
- Table 30 South Africa Veterinary Vaccines Market Size, By Disease, By Value, 2019–2030
- Table 31 South Africa Veterinary Vaccines Market Size, By Distribution Channel, By Value, 2019–2030
- Table 32 Nigeria Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
- Table 33 Nigeria Veterinary Vaccines Market Size, By Type, By Value, 2019–2030
- Table 34 Nigeria Veterinary Vaccines Market Size, By Technology, By Value, 2019–2030
- Table 35 Nigeria Veterinary Vaccines Market Size, By Disease, By Value, 2019–2030
- Table 36 Nigeria Veterinary Vaccines Market Size, By Distribution Channel, By Value, 2019–2030
- Table 37 Algeria Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
- Table 38 Algeria Veterinary Vaccines Market Size, By Type, By Value, 2019–2030
- Table 39 Algeria Veterinary Vaccines Market Size, By Technology, By Value, 2019–2030
- Table 40 Algeria Veterinary Vaccines Market Size, By Disease, By Value, 2019–2030
- Table 41 Algeria Veterinary Vaccines Market Size, By Distribution Channel, By Value, 2019–2030
- Table 42 Rest of MEA Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030
- Table 43 Rest of MEA Veterinary Vaccines Market Size, By Type, By Value, 2019–2030
- Table 44 Rest of MEA Veterinary Vaccines Market Size, By Technology, By Value, 2019–2030
- Table 45 Rest of MEA Veterinary Vaccines Market Size, By Disease, By Value, 2019–2030
- Table 46 Rest of MEA Veterinary Vaccines Market Size, By Distribution Channel, By Value, 2019–2030
- Table 47 BIOVAC Company Overview
- Table 48 BIOVAC Financial Overview
- Table 49 Boehringer Ingelheim International GmbH Company Overview
- Table 50 Boehringer Ingelheim International GmbH Financial Overview
- Table 51 Ceva Company Overview
- Table 52 Ceva Financial Overview
- Table 53 Elanco Company Overview
- Table 54 Elanco Financial Overview
- Table 55 Hester Biosciences Limited Company Overview
- Table 56 Hester Biosciences Limited Financial Overview
- Table 57 Merck & Co., Inc. Company Overview
- Table 58 Merck & Co., Inc. Financial Overview
- Table 59 NEOGEN Corporation Company Overview
- Table 60 NEOGEN Corporation Financial Overview
- Table 61 Virbac Company Overview
- Table 62 Virbac Financial Overview
- Table 63 Zoetis Inc. Company Overview
- Table 64 Zoetis Inc. Financial Overview
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook